DLCL
Showing 1 - 16 of 16
Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma Trial in China (Rituximab, Etoposide,
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Rituximab
- +8 more
-
Changsha, Hunan, China
- +5 more
Jan 24, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2022
Diffuse Large B Cell Lymphoma Trial in Italy (Treatment plan)
Completed
- Diffuse Large B Cell Lymphoma
- Treatment plan
-
Milano, MI, Italy
- +18 more
Feb 15, 2022
Diffuse Large B-Cell Lymphoma 18-fluoro-2-deoxyglycose Positron
Completed
- Diffuse Large B-cell Lymphoma
-
New York, New YorkWeill Cornell Medical College
May 25, 2018
Lymphoma Trial in Stanford (Bexxar, Acetaminophen, Diphenhydramine)
Completed
- Lymphoma
- Bexxar
- +3 more
-
Stanford, CaliforniaStanford University School of Medicine
Feb 28, 2017
Diffuse Large B-cell Lymphoma Trial in Shi Jiazhuang (PL-doxorubicin and epirubicin)
Unknown status
- Diffuse Large B-cell Lymphoma
- PL-doxorubicin and epirubicin
-
Shi Jiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jan 13, 2017
Diffuse Large Cell Lymphoma Trial in Belgium, France, Switzerland (Darbepoetin alfa)
Completed
- Diffuse Large Cell Lymphoma
- Darbepoetin alfa
-
Gent, Belgium
- +13 more
Sep 1, 2015
Non-Hodgkin Lymphoma in Elderly Patients Above Age of 80 in
Completed
- Non-Hodgkin's Lymphoma
- (no location specified)
Jun 30, 2014
Lymphoma, Diffuse Large Cell Trial in St. Louis (Blood draw)
Completed
- Lymphoma
- Diffuse Large Cell
- Blood draw
-
St. Louis, MissouriWashington University School of Medicine
May 14, 2013
DLBCL, IPI=2 Trial in Italy (Rituximab, Ciclofosfamide, Doxorubicina)
Unknown status
- Diffuse Large B-Cell Lymphoma
- IPIā„2
- Rituximab
- +11 more
-
Nocera Inferiore, Salerno, Italy
- +74 more
Feb 14, 2011
Lymphoma, B Cell Trial in Bellinzona (rituximab, CHOP, intrathecal methotrexate)
Completed
- Lymphoma, B Cell
- rituximab
- +3 more
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Jul 21, 2009